Corrosion mitigation is undergoing a strategic shift driven by tightening environmental regulation and the need for durable protection in increasingly aggressive operating environments. Green corrosion inhibitors—derived from renewable and biodegradable sources—offer clear advantages in toxicity and end-of-life footprint, yet their performance often varies with extract composition, temperature, flow, and electrolyte complexity. Hybrid inhibitor systems, which pair green organics with inorganic additives (e.g., nanoparticles, rare-earth salts, or functional fillers), are emerging as a pragmatic route to industrial reliability by combining strong adsorption chemistry with enhanced barrier integrity and, in some designs, multifunctionality such as anti-biofouling or self-healing. Here we synthesize mechanistic evidence across adsorption pathways (physisorption, chemisorption, and mixed adsorption), electrochemical blocking modes, surface characterization signatures, and computational descriptors linking electronic structure to adsorption propensity. We then critically examine what constitutes convincing validation—especially under realistic service constraints—and map inhibitor classes and hybrid architectures to high-priority sectors including oil and gas, marine/offshore systems, reinforced concrete, and process equipment. We argue that the central challenge is no longer demonstrating high inhibition efficiency in simplified laboratory media, but establishing reproducible, standardized, and life-cycle-credible performance. We conclude with a prioritized roadmap for designing robust hybrids, integrating data-driven discovery with field-relevant testing and circular-economy feedstocks.
Al‐Amiery et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: